Product and Partners
ChondroJoint® is a polynucleotide gel for the treatment of painful joint diseases, to be injected directly into the joint.
Medevice is a wholly owned subsidiary of Medestea Internationale, based in Turin, Italy. Medevice is focusing on the research & development of medical devices.
Review, compilation, and revision of sales docs.
Identification of potential licensors in Germany.
Contact, management, and negotiation of the target companies.
Organization of management presentations.
Negotiation of the licensing term.
Waterbergh acted on behalf of the licensee Medevice, Turin, Italy.